| Accession Number | 0001464521-26-000018 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Exercise/Conversion | 19,401 | $2.22 | $43,070.22 | 93,572 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Exercise/Conversion | 39,709 | $8.33 | $330,775.97 | 133,281 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Exercise/Conversion | 7,906 | $2.22 | $17,551.32 | 141,187 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Sale | 65,153 | $24.49 | $1,595,486.21 | 76,034 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 12, 2026 | Exercise/Conversion | 39,709 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 12, 2026 | Exercise/Conversion | 19,401 | $0.00 | $0.00 | 216,433 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 12, 2026 | Exercise/Conversion | 7,906 | $0.00 | $0.00 | 208,527 | Direct | โ | View Details |